Correlation Between Cigna Corp and PAVmed Series

Can any of the company-specific risk be diversified away by investing in both Cigna Corp and PAVmed Series at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cigna Corp and PAVmed Series into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cigna Corp and PAVmed Series Z, you can compare the effects of market volatilities on Cigna Corp and PAVmed Series and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cigna Corp with a short position of PAVmed Series. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cigna Corp and PAVmed Series.

Diversification Opportunities for Cigna Corp and PAVmed Series

0.3

Correlation Coefficient

Cigna Corp  PAVmed Series

Weak diversification

The 3 months correlation between Cigna and PAVmed is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and PAVmed Series Z in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PAVmed Series Z and Cigna Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cigna Corp are associated (or correlated) with PAVmed Series. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PAVmed Series Z has no effect on the direction of Cigna Corp i.e., Cigna Corp and PAVmed Series go up and down completely randomly.

Pair Corralation between Cigna Corp and PAVmed Series

Allowing for the 90-day total investment horizon Cigna Corp is expected to under-perform the PAVmed Series. But the stock apears to be less risky and, when comparing its historical volatility, Cigna Corp is 29.76 times less risky than PAVmed Series. The stock trades about -0.15 of its potential returns per unit of risk. The PAVmed Series Z is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  2.01  in PAVmed Series Z on September 25, 2024 and sell it today you would lose (1.07) from holding PAVmed Series Z or give up 53.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	51.56%
Values	Daily Returns

Cigna Corp  vs.  PAVmed Series Z

Cigna Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cigna Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

PAVmed Series Z

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Series Z are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent primary indicators, PAVmed Series showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cigna Corp and PAVmed Series

The main advantage of trading using opposite Cigna Corp and PAVmed Series positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cigna Corp position performs unexpectedly, PAVmed Series can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PAVmed Series will offset losses from the drop in PAVmed Series' long position.

The idea behind Cigna Corp and PAVmed Series Z pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.